Tranquis Therapeutics, Inc. is a pioneering clinical-stage biopharmaceutical company based in Redwood City, CA. They are dedicated to developing a portfolio of small molecule drugs that can reprogram dysfunctional myeloid immune cells, restoring normal cell homeostasis and function. By targeting master regulators of cell energy metabolism, such as PGC1, their therapeutic candidates have the potential to revolutionize the management of a wide range of immune-mediated and mitochondrial diseases, including ALS, and improve the lives of millions worldwide.
With their expertise, innovation, and commitment to advancing the treatment of immune-mediated and mitochondrial diseases, Tranquis Therapeutics is poised to transform the field. They have a promising pipeline of drug candidates in clinical and pre-clinical development, ready to address various diseases. Joining their collaborative and passionate workplace offers compelling career opportunities for individuals driven to make a difference in patients' lives.
Generated from the website